Source: Eur Respir J, 49 (6) 1700546; 10.1183/13993003.00546-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Amedeo Lonardo, Fabio Nascimbeni, Maurizio Ponz de Leon. Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?. Eur Respir J, 49 (6) 1700546; 10.1183/13993003.00546-2017

Member's Comments

No comment yet.

Related content which might interest you: Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016 Year: 2017 Relationship between OSA and non-alcoholic fatty liver disease Source: ERS Conference Year: 2015 Non-alcoholic fatty liver disease (NAFLD): A new mechanism for co-morbidities in chronic obstructive pulmonary disease (COPD)? Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea Year: 2011 1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease Source: ERJ Open Res, 7 (3) 00103-2021; 10.1183/23120541.00103-2021 Year: 2021 Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease. Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019 Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Association between obstructive sleep apnea and nonalcoholic fatty liver disease Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019 Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006 In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction Source: Annual Congress 2012 - Sleep disorders in internal medicine Year: 2012 The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease. Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Impact of non-alcoholic fatty liver disease on late cardiovascular events and death in Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Fatty airways: implications for obstructive disease Source: Eur Respir J, 54 (6) 1900857; 10.1183/13993003.00857-2019 Year: 2019 Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids? Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2008; 31: 1024-1029 Year: 2008 The role of free fatty acids in idiopathic pulmonary fibrosis Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 An application of omega-3 polyunsaturated fatty acids in treatment of COPD patients with pulmonary hypertension and chronic cor pulmonale Source: Eur Respir J 2001; 18: Suppl. 33, 251s Year: 2001 The influence of obstructive sleep apneao–induced  intermittant Hypoxia on Non Alcoholic  Fatty  liver. Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea Year: 2017 Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon? Source: Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021 Year: 2021 The lipokine, or palmitoleic acid (16:1), is a biomarker of lung function in chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014